Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong.

@article{Cheng2019ExperienceOC,
  title={Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong.},
  author={Shirley S W Cheng and Kelvin Yuen Kwong Chan and Kelphen K P Leung and Patrick K. C. Au and Wai-Keung Tam and Samuel K M Li and Ho Ming Luk and Anita Sik Yau Kan and Brian Hon-Yin Chung and Ivan F. M. Lo and Mary H. Y. Tang},
  journal={American journal of medical genetics. Part C, Seminars in medical genetics},
  year={2019},
  volume={181 2},
  pages={
          196-207
        }
}
Chromosomal microarray (CMA) is recommended as a first tier investigation for patients with developmental delay (DD), intellectual disability (ID), autistic spectrum disorder (ASD), and multiple congenital anomalies (MCA). It is widely used in the prenatal and postnatal settings for detection of chromosomal aberrations. This is a retrospective review of all array comparative genomic hybridization (aCGH/ array CGH) findings ascertained in two major prenatal and postnatal genetic diagnostic… CONTINUE READING
BETA